Regdanvimab improves disease mortality and morbidity in patients with COVID-19: a meta-analysis. Yang M, Li A, Jiang L, Wang Y, et al. J Infect 2022 Jun 18. pii: S0163-4453(22)00369.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Yang M, Li A, Jiang L, Wang Y, et al. Regdanvimab improves disease mortality and morbidity in patients with COVID-19: a meta-analysis. J Infect 2022 Jun 18. pii: S0163-4453(22)00369.
PMID: 35728643